By Debdeep Gupta | 03 Sep, 2026
Meesho block deal: 1.7% stake worth Rs 1,650 crore changes hands; SoftBank likely seller
A 1.7 percent stake in Meesho Ltd worth Rs 1,650.4 crore changed hands through a block deal on Thursday, with SoftBank likely to be the seller. As many as 8 crore shares of Meesho were sold at Rs 206.3 apiece, representing a 2.5 percent discount to the stock’s previous closing price of Rs 211.6.Earlier yesterday, reports said that Japanese investment major Softbank was looking to pare its holdin...
Live Comments
Arvind01 2025-06-19 15:09:06
A pharmaceutical company announced that a recent inspection by the U.S. Food and Drug Administration (FDA) at its oncology injectable facility in Ahmedabad ended with two observations, neither of which relate to data integrity.
Login & Reply Like(0) Dislike(0) Repost SpamProfitGainer01 2025-03-19 11:10:57
Pharma company gets USFDA nod for 60mg Apalutamide tablets, used for prostate cancer. The drug had $1.1B in US sales.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2025-02-27 09:22:43
The company introduced India's first flu protection quadrivalent influenza virus vaccine, VaxiFlu-4, offering seasonal protection against four new virus strains. The vaccine has been cleared by the Central Drug Laboratory (CDL) and aims to address the public health challenge posed by seasonal influenza outbreaks.
Login & Reply Like(0) Dislike(0) Repost SpamArvind01 2025-02-17 11:27:38
Zydus Lifesciences announced the successful completion of a US FDA surveillance inspection at its API (active pharmaceutical ingredient) manufacturing facility in Ambernath, Maharashtra. The inspection, conducted from February 10 to 14, 2025, concluded with no observations.
Login & Reply Like(0) Dislike(0) Repost Spam